We observed that NTN-1 administration ameliorated memory and cognitive ability in Aβ1-42-induced AD rats at a concentration of 160 ng/μL, but effective concentration range of NTN-1 in the central nervous system remains further investigation (Lv et al., 2015). This evidence concerns the gene NTN1 and Alzheimer disease.